Wills Robert J.'s most recent trade in Milestone Pharmaceuticals Inc was a trade of 40,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Milestone Pharmaceuticals Inc | Robert J. Wills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Milestone Pharmaceuticals Inc | Robert J. Wills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2024 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Oncternal Therapeutics Inc | Robert J. Wills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 2,200 | 2,200 | - | - | Stock Options | |
| Oncternal Therapeutics Inc | Robert J. Wills | Director | Purchase of securities on an exchange or from another person at price $ 8.96 per share. | 08 Apr 2024 | 3,086 | 10,000 (0%) | 0% | 9.0 | 27,655 | Common Stock |
| Oncternal Therapeutics Inc | Robert J. Wills | Director | Purchase of securities on an exchange or from another person at price $ 8.48 per share. | 28 Mar 2024 | 6,914 | 6,914 (0%) | 0% | 8.5 | 58,602 | Common Stock |
| Cymabay Therapeutics Inc | Robert J. Wills | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 67,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Robert J. Wills | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 49,245 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Robert J. Wills | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 32,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Robert J. Wills | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 30,000 | 0 (0%) | 0% | - | Common Stock | |
| Cymabay Therapeutics Inc | Robert J. Wills | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 27,705 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Robert J. Wills | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 27,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Robert J. Wills | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 25,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Robert J. Wills | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 25,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Robert J. Wills | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 18,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Robert J. Wills | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 16,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Robert J. Wills | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 15,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Robert J. Wills | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 14,010 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Robert J. Wills | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 9,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Robert J. Wills | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 7,500 | 0 | - | - | Employee Stock Option (right to buy) | |
| Oncternal Therapeutics Inc | Wills Robert J. | Director | Sale of securities on an exchange or to another person at price $ 9.04 per share. | 23 Feb 2024 | 980 | 0 (0%) | 0% | 9.0 | 8,859 | Common Stock |
| Cymabay Therapeutics Inc | Wills Robert J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 14,010 | 14,010 | - | - | Stock Option (right to buy) | |
| Oncternal Therapeutics Inc | Robert J. Wills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 25,000 | 25,000 | - | - | Stock Options | |
| Milestone Pharmaceuticals Inc | Robert J. Wills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Robert J. Wills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Milestone Pharmaceuticals Inc | Robert J. Wills | Director | Purchase of securities on an exchange or from another person at price $ 4.93 per share. | 19 Oct 2022 | 15,000 | 15,000 (0%) | 0% | 4.9 | 73,950 | Common Shares |
| Milestone Pharmaceuticals Inc | Robert J. Wills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Oncternal Therapeutics Inc | Robert J. Wills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 25,000 | 25,000 | - | - | Stock Options | |
| Cymabay Therapeutics Inc | Robert J. Wills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 67,000 | 67,000 | - | - | Stock Option (right to buy) | |
| Milestone Pharmaceuticals Inc | Robert J. Wills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Oncternal Therapeutics Inc | Robert J. Wills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 25,000 | 25,000 | - | - | Stock Options | |
| Cymabay Therapeutics Inc | Robert J. Wills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 32,000 | 32,000 | - | - | Stock Option (right to buy) | |
| Milestone Pharmaceuticals Inc | Robert J. Wills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 30,000 | 30,000 | - | - | Stock Option (right to buy) |